Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar;206(3):899-906.
doi: 10.1111/bjh.19957. Epub 2024 Dec 25.

Monoclonal gammopathy of undetermined significance and the risk of thrombotic events: Results from iStopMM, a prospective population-based screening study

Sæmundur Rögnvaldsson  1   2 , Alessandro Gasparini  3 , Sigrun Thorsteinsdottir  1   4 , Ingigerdur Sverrisdottir  1   5 , Elias Eythorsson  2 , Thorir Einarsson Long  1   6 , Robert Palmason  1   6 , Brynjar Vidarsson  2 , Pall Torfi Onundarson  1 , Bjarni A Agnarsson  1   2 , Margret Sigurdardottir  2 , Isleifur Olafsson  2 , Ingunn Thorsteinsdottir  2 , Jon Thorir Oskarsson  1   2 , Asbjorn Jonsson  7 , Runolfur Palsson  1   2 , Olafur Skuli Indriðason  2 , Andri Olafsson  1 , Malin Hultcrantz  8 , Brian G M Durie  9 , Stephen Harding  10 , Ola Landgren  11 , Thorvardur Jon Love  1   2 , Sigurdur Yngvi Kristinsson  1   2
Affiliations

Monoclonal gammopathy of undetermined significance and the risk of thrombotic events: Results from iStopMM, a prospective population-based screening study

Sæmundur Rögnvaldsson et al. Br J Haematol. 2025 Mar.

Abstract

Monoclonal gammopathy of undetermined significance (MGUS) is the asymptomatic precursor of multiple myeloma and related diseases but has also been associated with thrombosis. Prior studies have not been based on screened cohorts leading to bias. We assessed the risk of thrombosis in a cohort of 75 422 individuals over 40 years old who were screened for MGUS in Iceland. We also evaluated the association of M protein concentration with thrombotic risk. A total of 3668 participants had MGUS. After a median follow-up of ~3.7 years, 124 venous and 252 arterial thrombotic events (10.3 and 21.0 per 1000 person years respectively) were observed in the MGUS group, compared to 1509 and 3471 in the non-MGUS group (6.0 and 13.8 per 1000 person years respectively). After adjusting for multiple confounders, MGUS was associated with an increased risk of venous thrombosis (hazard ratio [HR] = 1.43; 95% confidence interval [CI]: 1.19-1.73) but not arterial thrombosis (HR = 0.96; 95% CI: 0.87-1.13). M protein concentration was not associated with venous (p = 0.72) or arterial (p = 0.95) thrombosis. The findings show, in a screened cohort, that MGUS is associated with venous, but not arterial, thrombosis. Furthermore, they suggest that there is a subset of individuals with MGUS with subclinical monoclonal gammopathy of thrombotic significance.

Keywords: epidemiology; monoclonal gammopathy of undetermined significance; risk factors; thrombosis; venous thrombosis.

PubMed Disclaimer

References

REFERENCES

    1. Kyle RA, Durie BGM, Rajkumar SV, Landgren O, Blade J, Merlini G, et al. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management. Leukemia. 2010;24(6):1121–1127.
    1. Landgren O, Kyle RA, Pfeiffer RM, Katzmann JA, Caporaso NE, Hayes RB, et al. Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study. Blood. 2009;113(22):5412–5417.
    1. Kyle RA, Therneau TM, Rajkumar SV, Remstein ED, Offord JR, Larson DR, et al. Long‐term follow‐up of IgM monoclonal gammopathy of undetermined significance. Blood. 2003;102(10):3759–3764.
    1. Kyle RA, Therneau TM, Rajkumar SV, Larson DR, Plevak MF, Offord JR, et al. Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med. 2006;354(13):1362–1369.
    1. Turesson I, Kovalchik SA, Pfeiffer RM, Kristinsson SY, Goldin LR, Drayson MT, et al. Monoclonal gammopathy of undetermined significance and risk of lymphoid and myeloid malignancies: 728 cases followed up to 30 years in Sweden. Blood. 2014;123(3):338–345.

LinkOut - more resources